Search

Displaying results 4421 - 4430 of 10000 in total
  1. Drug

    Dansylamide

    go.drugbank.com/drugs/DB02866
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Dovitinib

    go.drugbank.com/drugs/DB05928
    Investigational

    Dovitinib is an orally active small molecule that exhibits potent inhibitory activity against multiple RTKs involved in tumor growth and angiogenesis. … Chiron currently has three ongoing Phase I clinical trials for dovitinib.

  3. Drug

    Regramostim

    go.drugbank.com/drugs/DB05386
    Investigational

    Endothelial cells and fibroblasts can also produce GM-CSF after exposure to TNF-α, IL-1, IL-2 and IFN-γ. GM-CSF is found associated with extracellular matrix and in membrane-bound formats too. … Regramostim (GM-CSF) is a differentially glycosylated factor produced mainly by activated T cells and macrophages.

  4. Drug

    Talmapimod

    go.drugbank.com/drugs/DB05412
    Investigational

    Talmapimod is the first-generation oral p38 MAP kinase inhibitor developed by Scios. It has shown to be effective to cure inflammatory diseases such as Rheumatoid Arthritis.

  5. Drug

    Siplizumab

    go.drugbank.com/drugs/DB06371
    Investigational

  6. Drug

    MD-0727

    go.drugbank.com/drugs/DB05948
    Investigational

    MD-0727 is a novel, potent cholesterol absorption inhibitor (CAI) under investigation for the treatment of hypercholesterolemia (high cholesterol.

  7. Drug

    Alicaforsen

    go.drugbank.com/drugs/DB06224
    Investigational

  8. Drug

    Azlocillin

    go.drugbank.com/drugs/DB01061
    Approved

    Azlocillin is a semisynthetic ampicillin-derived acylureido penicillin.

  9. Drug

    Mitonafide

    go.drugbank.com/drugs/DB19492
    Experimental

    Mitonafide is a small molecule drug. Mitonafide has a monoisotopic molecular weight of 313.11 Da.

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    AOD9604

    go.drugbank.com/drugs/DB06388
    Experimental

    AOD9604 is a synthetic analogue of the lipolytic domain of human growth hormone, being investigated for the treatment of obesity.